![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Pharmacological Institute, College of Medicine (W.-L.C., C-M.T., W.-M.F.) and Department of Psychology (K.-C.L.), National Taiwan University; Taipei, Taiwan; Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung, Taiwan (S.-C.K., F.-Y.L.)
Nitric oxide (NO) is known to affect synaptic plasticity in various regions of the brain via the cGMP–cGMP-dependent protein kinase (PKG) pathway. We found that a novel compound 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole (YC-1), a drug known to modulate the response of soluble guanylyl cyclase to NO, greatly potentiates long-term potentiation (LTP). This compound markedly enhanced the induction of LTP in rat hippocampal and amygdala slices by weak tetanic stimulation. The potentiation of LTP by YC-1 was greatly reduced by NO synthase inhibitor NG-nitro-L-arginine-methylester, guanylyl cyclase inhibitor 1 H-[1,2,4]-oxadiazolo(4,3-a)-quinoxalin-1-one, and PKG inhibitor (9S,10R,12R)-2,3,9,10,11,12, hexahydro-10-methoxy-2,9-dimethyl-1-ox0–9.12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-I][1,6]benzodiazocine-10-carboxylic acid methyl ester (KT5823). In addition, mitogen-activated protein kinase kinase inhibitor 2'-amino-3'-methoxyflavone (PD98059) also markedly inhibited LTP potentiating action of YC-1. Intracellular increase of Ca2+ concentration derived from N-methyl-D-aspartate and glutamate metabotropic receptors contributes to the potentiating action of YC-1. Concurrent perfusion of YC-1 and NO donor sodium nitroprusside for a short time period resulted in the induction of LTP by stimuli at a frequency as low as 0.02 Hz. Incubation of unstimulated hippocampal slices with YC-1 plus nitroprusside increased the immunofluorescence of phospho-extracellular signal-regulated kinase (ERK) and phospho-cAMP response element binding protein (CREB). Furthermore, the Western blot shows that the phosphorylation of ERKs 1 and 2 and CREB of unstimulated hippocampal slices was increased by YC-1 plus nitroprusside, which was inhibited by KT5823. The NO-cGMP-PKG-ERK signaling pathway thus plays important role in the potentiation of LTP by YC-1.
Address correspondence to: Wen-Mei Fu, Pharmacological Institute, College of Medicine, National Taiwan University, 1, Sec. 1, Jen-Ai Road, Taipei, Taiwan. E-mail: wenmei{at}ccms.ntu.edu.tw
This article has been cited by other articles:
|
|
 |
|
  K. T. Ota, V. J. Pierre, J. E. Ploski, K. Queen, and G. E. Schafe The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase Learn. Mem., October 2, 2008; 15(10): 792 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sabatini, P. Ebert, D. A. Lewis, P. Levitt, J. L. Cameron, and K. Mirnics Amygdala Gene Expression Correlates of Social Behavior in Monkeys Experiencing Maternal Separation J. Neurosci., March 21, 2007; 27(12): 3295 - 3304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yazawa, H. Tsuchiya, H. Hori, and R. Makino Functional Characterization of Two Nucleotide-binding Sites in Soluble Guanylate Cyclase J. Biol. Chem., August 4, 2006; 281(31): 21763 - 21770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-L. Pan, J.-H. Guh, C.-Y. Peng, S.-W. Wang, Y.-L. Chang, F.-C. Cheng, J.-H. Chang, S.-C. Kuo, F.-Y. Lee, and C.-M. Teng YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] Inhibits Endothelial Cell Functions Induced by Angiogenic Factors in Vitro and Angiogenesis in Vivo Models J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Bredt Nitric Oxide Signaling in Brain: Potentiating the Gain with YC-1 Mol. Pharmacol., June 1, 2003; 63(6): 1206 - 1208. [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
